Volume | 687,683 |
|
|||||
News | - | ||||||
Day High | 9.345 | Low High |
|||||
Day Low | 8.985 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.06 | 8.985 | 9.345 | 9.03 | 9.25 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
6,133 | 687,683 | US$ 9.14 | US$ 6,283,159 | - | 8.93 - 26.63 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 48,669 | US$ 9.03 | USD |
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
328.31M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.26 | 9.78 | 8.985 | 9.36 | 404,519 | -0.23 | -2.48% |
1 Month | 11.18 | 11.65 | 8.93 | 9.66 | 504,442 | -2.15 | -19.23% |
3 Months | 13.76 | 14.70 | 8.93 | 11.06 | 513,660 | -4.73 | -34.38% |
6 Months | 21.19 | 22.64 | 8.93 | 14.52 | 508,265 | -12.16 | -57.39% |
1 Year | 24.00 | 26.63 | 8.93 | 17.31 | 531,933 | -14.97 | -62.38% |
3 Years | 159.01 | 182.45 | 8.93 | 49.95 | 554,754 | -149.98 | -94.32% |
5 Years | 63.23 | 188.14 | 8.93 | 74.03 | 492,958 | -54.20 | -85.72% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |